(MENAFN - America News Hour) Market Forecast
The Global Immunosuppressive Drugs Market is expected to cross USD 1.39 Billion by 2025 at a CAGR of 4.63%. Immunosuppressants are generally used post organ transplants and for the treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis. According to the World Health Organization (WHO) and the Spanish Transplant Organization, Organización Nacional de Trasplantes (ONT), in 2018, organ transplants increased by 7.25% from the previous year to reach approximately 138,000, including 40.4% living kidney transplants and 19.8% living liver transplants.
Download Sample of This Strategic Report-
Market Synopsis
Immunosuppressive drugs find utility post organ transplants when the receiver s immunity must be suppressed for the body to accept the newly attached organ.This market is growing due to the increasing number of organ transplants and advances in tissue engineering and organ transplant techniques